← Back to Search

Behavioral Intervention

Arm 2 Consumption for Peanut Allergy (ESCAPE Trial)

N/A

Waitlist Available

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

ESCAPE Trial Summary

"This trial will study how a baby's risk of developing allergies to peanuts and eggs is affected by the mother's diet during pregnancy and breastfeeding."

Who is the study for?

This study is for expecting mothers who are not allergic to peanuts or eggs. It's designed to see if eating or avoiding these foods during pregnancy and breastfeeding affects their baby's risk of developing food allergies.Check my eligibility

What is being tested?

The trial is testing the impact of maternal diet on infant allergy development. Specifically, it looks at whether mothers consuming or avoiding peanuts and eggs can influence their child's likelihood of having a peanut or egg allergy.See study design

What are the potential side effects?

Since this trial involves dietary choices rather than medication, there aren't typical side effects. However, there may be risks associated with nutritional changes for the mother and potential allergy development in infants.

ESCAPE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ four months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~four months

This trial's timeline: 3 weeks for screening, Varies for treatment, and four months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Egg sensitization

Secondary outcome measures

Antibodies in maternal blood

Antigen concentrations

Egg allergy

+1 more

Other outcome measures

Exploratory: Peanut sensitization

Exploratory: Symptoms

ESCAPE Trial Design

2Treatment groups

Active Control

Group I: Arm 2 ConsumptionActive Control1 Intervention

Subjects must consume peanuts and peanut products and egg and egg products.

Group II: Arm 1 AvoidanceActive Control1 Intervention

Subjects must avoid eating peanuts and peanut products and egg and egg products.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Allergy and Infectious Diseases (NIAID)NIH

3,270 Previous Clinical Trials

5,484,837 Total Patients Enrolled

University of RochesterLead Sponsor

840 Previous Clinical Trials

533,850 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which specific criteria must individuals meet to be eligible for enrollment in this research study?

"To qualify for this research study, candidates must possess a background in allergy and immunology and fall within the age bracket of 18 to 40 years. The aim is to recruit a cohort of 400 participants."

Answered by AI

Are there still available slots for patients to participate in this ongoing clinical trial?

"As per clinicaltrials.gov, the ongoing trial is currently not accepting new participants. It was initially listed on September 1st, 2024, with the latest update noted on February 7th, 2024. Although this specific study has reached its recruitment capacity, there are a total of 266 alternative trials welcoming interested individuals to participate."

Answered by AI